Do endothelial progenitor cells modify our strategy to treat risk factors?
Κύριοι συγγραφείς: | Tousoulis, D, Andreou, I, Antoniades, C, Siasos, G, Stougiannos, P, Trikas, A, Stefanadis, C |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2011
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Do endothelial progenitor cells modify our strategy to treat risk factors?
ανά: Tousoulis, D, κ.ά.
Έκδοση: (2010) -
Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
ανά: Andreou, I, κ.ά.
Έκδοση: (2006) -
Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
ανά: Tousoulis, D, κ.ά.
Έκδοση: (2008) -
Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.
ανά: Bakogiannis, C, κ.ά.
Έκδοση: (2012) -
The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
ανά: Briasoulis, A, κ.ά.
Έκδοση: (2011)